290 related articles for article (PubMed ID: 18393011)
21. Pharmacologic treatment of stress urinary incontinence: expectations for outcome.
Schuessler B; Baessler K
Urology; 2003 Oct; 62(4 Suppl 1):31-8. PubMed ID: 14550835
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
Puyol M; Collado A
Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
[TBL] [Abstract][Full Text] [Related]
24. Innovations in pharmacotherapy for stress urinary incontinence.
Cannon TW; Yoshimura N; Chancellor MB
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Dec; 14(6):367-72. PubMed ID: 14676995
[TBL] [Abstract][Full Text] [Related]
25. [New options in pharmacological treatment of urinary stress incontinence in women].
Martan A
Ceska Gynekol; 2004 Nov; 69(6):500-6. PubMed ID: 15633423
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
27. Duloxetine in women awaiting surgery.
Drutz H
BJOG; 2006 May; 113 Suppl 1():17-21. PubMed ID: 16529565
[TBL] [Abstract][Full Text] [Related]
28. Duloxetine: a dual reuptake inhibitor.
Dugan SE; Fuller MA
Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
[TBL] [Abstract][Full Text] [Related]
29. [Place of duloxetine in the treatment of stress urinary incontinence].
Rouprêt M; Richard F; Chartier-Kastler E
Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
[TBL] [Abstract][Full Text] [Related]
30. New developments in the management of stress urinary incontinence.
Cardozo L
BJU Int; 2004 Jul; 94 Suppl 1():1-3. PubMed ID: 15139856
[No Abstract] [Full Text] [Related]
31. Duloxetine for male stress incontinence.
Chapple CR
Eur Urol; 2006 Jun; 49(6):958-60. PubMed ID: 16522351
[No Abstract] [Full Text] [Related]
32. Role of serotonin and noradrenaline in stress urinary incontinence.
Michel MC; Peters SL
BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860
[No Abstract] [Full Text] [Related]
33. Neurobiology of stress urinary incontinence: new insights and implications for treatment.
Cardozo L
J Obstet Gynaecol; 2005 Aug; 25(6):539-43. PubMed ID: 16234136
[TBL] [Abstract][Full Text] [Related]
34. The use of duloxetine for stress incontinence after prostatectomy.
Hotston MR; Hurley K; Patel S; Persad R
BJU Int; 2006 Oct; 98(4):916-7. PubMed ID: 16978296
[No Abstract] [Full Text] [Related]
35. Pharmacotherapy for stress urinary incontinence.
Castro-Diaz D; Amoros MA
Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine pharmacology: profile of a dual monoamine modulator.
Karpa KD; Cavanaugh JE; Lakoski JM
CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
38. Duloxetine as a treatment for stress incontinence--where are we now?
Duckett J
Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jan; 19(1):1-3. PubMed ID: 17898920
[No Abstract] [Full Text] [Related]
39. Safety and tolerability of duloxetine in women with stress urinary incontinence.
Oelke M; Roovers JP; Michel MC
BJOG; 2006 May; 113 Suppl 1():22-6. PubMed ID: 16529566
[TBL] [Abstract][Full Text] [Related]
40. What do we know about duloxetine's mode of action? Evidence from animals to humans.
Schuessler B
BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
